Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 2, 1997, Pages 147-155

  Tout, Nancy L ^a   Lam, Joseph S ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; IMMUNOTHERAPY; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEROTYPE;

EID: 0030939431     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.2.147-155.1997     Document Type: Article

References (56)

1. Alfthan, K., K. Takkinen, D. Sizmann, I. Seppala, T. Immonen, L. Vanne, S. Keranen, M. Kaartinen, J. K. C. Knowles, and T. T. Teeri. 1993. Efficient secretion of murine Fab fragments by Escherichia coli is determined by the first constant domain of the heavy chain. Gene 128:203-209.
2. Barbas, C. F., III, and R. A. Lerner. 1991. Combinatorial immunoglobulin libraries on the surface of phage (Phabs): rapid selection of antigen-specific Fabs. Methods Comp. Methods Enzymol. 2:119-124.
3. Barbas, C., III, A. Kang, R. Lerner, and S. Benkovic. 1991. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. USA 88:7978-7982.
4. Better, M., C. Cheng, R. Robinson, and A. Horowitz. 1988. Escherichia coli secretion of an active chimeric antibody fragment. Science 240:1041-1043.
5. Bone, R. C. 1993. Gram-negative sepsis: a dilemma of modern medicine. Clin. Microbiol. Rev. 6:57-68.
6. Bradbury, A., F. Ruberti, T. Werge, V. Amati, A. Di Luzio, S. Gontloni, H. Hoogenboom, P. Piccioli, S. Biocca, and A. Cattaneo. 1995. The cloning of hybridoma V regions for their ectopic expression in intracellular and intercellular immunization, p. 295-361. In A. K. Borrebaeck (ed.), Antibody engineering, 2nd ed. Oxford University Press, New York, N.Y.
7. Carroll, P., D. Stafford, R. Schwartz, and B. Stollar. 1985. Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria. J. Immunol. 135:1086-1090.
8. Clackson, T., H. Hoogenboom, A. Griffiths, and G. Winter. 1991. Making antibody fragments using phage display libraries. Nature 352:624-628.
9. Cryz, S. J., Jr., E. Fürer, and R. Germanier. 1983. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide. Infect. Immun. 39:1072-1079.
10. Cryz, S. J., Jr., T. L. Pitt, E. Fürer, and R. Germanier. 1984. Role of lipopolysaccharide in the virulence of Pseudomonas aeruginosa. Infect. Immun. 44:508-513.
11. Darsley, M., and A. Rees. 1985. Nucleotide sequences of five anti-lysozyme monoclonal antibodies. EMBO J. 4:393-398.
12. κ genes encode antibodies to Pseudomonas aeruginosa LPS. J. Immunol. 155:3912-3921.
13. Emara, M., D. Malburg, and J. Lam. 1995. Expression of an anti-Pseudomonas aeruginosa lipopolysaccharide core recombinant antibody in Escherichia coli. J. Endotoxin Res. 2:53-61.
14. Fisher, M. 1977. A polyvalent human γ-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection. J. Infect. Dis. 136(Suppl.):S181-S185.
15. Gram, H., L. Marconi, C. Barbas III, T. Collet, R. Lerner, and A. Kang. 1992. In vitro selection and affinity maturation of antibodies from a naïve combinatorial immunoglobulin library. Proc. Natl. Acad. Sci. USA 89:3576-3580.
16. Hitchcock, P., and T. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
17. Hong, H., A. Kim, C. Ryu, S. Park, H. Chung, K. Kwon, K. Kim, J. Kim, and M. Han. 1992. Cloning and characterization of cDNAs coding for heavy and light chains of a monoclonal antibody specific for pre-S2 antigen of hepatitis B virus. Gene 121:331-335.
18. Houghton, A., D. Mintzer, and C. Cordon-Cardo. 1985. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc. Natl. Acad. Sci. USA 82:1242-1246.
19. Kabat, E., K. Nickerson, J. Liao, L. Grossbard, E. Osserman, E. Glickman, L. Chess, T. Robbins, R. Schneerson, and Y. Yang. 1986. A human monoclonal macroglobulin with specificity for alpha C-28 linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1 which cross reacts with polynucleotides and denatured DNA. J. Exp. Med. 164:642-654.
20. Kabat, E., T. Wu, H. Perry, K. Gottesman, and C. Foeller. 1991. Sequences of proteins of immunological interest, 4th ed. United States Department of Health and Human Services, Washington, D.C.
21. Kadurugamuwa, J. L., and T. J. Beveridge. 1995. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 177:3998-4008.
22. Kang, A., D. Burton, and R. Lerner. 1991. Combinatorial immunoglobulin libraries in phage λ. Methods Comp. Methods Enzymol. 2:111-118.
23. Kang, A., C. Barbas III, K. Janda, S. Benkovic, and R. Lerner. 1991. Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc. Natl. Acad. Sci. USA 88:4363-4366.
24. Khazaeli, M., M. Saleh, R. Wheeler, W. Huster, H. Holden, R. Carrano, and A. Lobuglio. 1988. Phase I trial of multiple large doses of murine monoclonal antibody C017-1A. II. Pharmacokinetics and immune response. J. Natl. Cancer Inst. 80:937-942.
25. Knirel, Y. 1990. Polysaccharide antigens of Pseudomonas aeruginosa. Crit. Rev. Mierobiol. 17:273-303.
26. Kofler, R., D. Noonan, D. Levy, M. Wilson, N. Møller, F. Dixon, and A. Theofilopoulos. 1985. Genetic elements used for a murine lupus anti-DNA autoantibody are closely related to those for antibodies to exogenous antigens. J. Exp. Med. 161:805-815.
27. Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
28. Lam, J., L. MacDonald, M. Lam, L. Duchesne, and G. Southam. 1987. Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa. Infect. Immun. 55:1051-1057.
29. Lang, A., J. Larrick, and S. Cryz, Jr. 1989. Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides. Infect. Immun. 57:3851-3855.
30. Liu, P. V., and S. P. Wang. 1990. Three new major somatic antigens of Pseudomonas aeruginosa. J. Clin. Microbiol. 28:922-925.
31. LoBuglio, A., M. Saleh, J. Lee, M. Khazeli, R. Carrano, H. Holden, and R. Wheeler. 1988. Phase I trial of multiple large doses of murine monoclonal antibody C017-1A. I. Clinical aspects. J. Natl. Cancer Inst. 80:932-936.
32. MacIntyre, S., R. Lucken, and P. Owen. 1986. Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV. Infect. Immun. 52:76-84.
33. McCafferty, J., A. Griffiths, G. Winter, and D. Chiswell. 1990. Phagc antibodies: filamentous phage displaying antibody variable domains. Nature 348:552-554.
34. Meeker, T., J. Lowder, D. Maloney, R. Miller, K. Thielemans, R. Warnke, and R. Levy. 1985. A clinical trial of anti-idiotype therapy for B cell malignancy. Blood 65:1349-1363.
35. Novick, K., T. Fasy, M. Losman, and M. Monestier. 1992. Polyreactive IgM antibodies generated from autoimmune mice and selected for histone-binding activity. Int. Immunol. 4:1103-1111.
36. O'Oka, H., E. Chonan, K. Mizutani, T. Fukuda, Y. Kuroiwa, Y. Ono, and S. Shigeta. 1992. Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice. Microbiol. Immunol. 36:1305-1316.
37. Orlandi, R., D. Gussow, P. Jones, and G. Winter. 1989. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:3833-3837.
38. Pennington, J., G. Small, M. Lostrom, and G. Pier. 1986. Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia. Infect. Immun. 54:239-244.
39. Pitt, T. L. 1988. Epidemiological typing of Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis. 7:238-247.
40. Pollack, M., N. Koles, M. Preston, B. Brown, and G. Pier. 1995. Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide. Infect. Immun. 63:4481-4488.
41. Poole, K., K. Krebes, C. McNally, and S. Neshat. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372.
42. Poole, K. 1994. Bacterial multidrug resistance - emphasis on efflux mechanisms and Pseudomonas aeruginosa. J. Antimicrob. Chemother. 34:453-456.
43. Reininger, L., T. Shibata, S. Ozaki, T. Shirai, J. Jaton, and S. Izui. 1990. Variable region sequences of pathogenic anti-mouse red blood cell autoantibodies from autoimmune NZB mice. Eur. J. Immunol. 20:771-777.
44. Roark, J., C. L. Kuntz, K. Nguyen, A. Caton, and J. Erikson. 1995. Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med. 181:1157-1167.
45. Sawada, S., M. Suzuki, T. Kawamura, S. Fujinaga, Y. Masuho, and K. Tomibe. 1984. Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins. J. Infect. Dis. 150:570-576.
46. Sawada, S., T. Kawamura, and Y. Masuho. 1987. Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa. J. Gen. Microbiol. 133:3581-3590.
47. Shoenfeld, Y., Y. Vilner, A. Coates, J. Rauch, G. Lavie, D. Shaul, and J. Pinkhas. 1986. Monoclonal anti-tuberculosis antibodies react with DNA and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin. Exp. Immunol. 66:255-261.
48. Skerra, A., and A. Pluckthun. 1988. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240:1038-1041.
49. Stoll, B., M. Pollack, L. Young, N. Koles, R. Gascon, and G. Pier. 1986. Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide. Infect. Immun. 53:656-662.
50. Suzuki, H., Y. Okubo, M. Moriyama, M. Sasaki, Y. Matsumoto, and T. Hozumi. 1987. Human monoclonal antibodies to Pseudomonas aeruginosa produced by EBV-transformed cells. Microbiol. Immunol. 31:959-966.
51. Terashima, M., I. Uezumi, T. Tomio, M. Kato, K. Irie, T. Okuda, S. Yokota, and H. Noguchi. 1991. A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide. Infect. Immun. 59:1-6.
52. 1 mice. J. Exp. Med. 176:761-779.
53. Tonge, D., J. Hennam, A. Greene, I. Lee, and M. Edge. 1993. Cloning and characterization of 1116NS19.9 heavy and light chain cDNAs and expression of antibody fragments in Escherichia coli. Year Immunol. 7:56-62.
54. 53a.Tout, N. L., and J. S. Lam. Unpublished results.
55. Zemel, R., D. Schindler, D. Tawfik, Z. Eshhar, and B. Green. 1993. Differences in the biochemical properties of esterolytic antibodies correlate with structural diversity. Mol. Immunol. 31:127-137.
56. Zweerink, H., M. Gammon, C. Hutchison, J. Jackson, D. Lombardo, K. Miner, J. Puckett, T. Sewell, and N. Sigal. 1988. Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa. Infect. Immun. 56:1873-1879.